HHS Confirms FDA Blocked Publication of Vaccine Studies
Similar Articles
Trump Administration Appeals Injunction Against CDC Vaccine Policy Changes
FDA Commissioner's Status Unclear Amid Reported Push for Removal
Health Secretary Announces Federal Initiatives to Curb Antidepressant Prescribing
FDA Commissioner Marty Makary Removed After Pressure Over Vape Approvals
House Removes Pesticide Lawsuit Shield From Farm Bill as White House Changes Surgeon General Nominee
The Department of Health and Human Services (HHS) has confirmed that the Food and Drug Administration (FDA) blocked the publication of studies on COVID-19 and shingles vaccines. This follows a separate report last month that the Centers for Disease Control and Prevention (CDC) scrapped a study showing vaccines sharply cut the risk of severe COVID-19 outcomes. The developments come as Health Secretary Robert F. Kennedy has pledged to provide 'radical transparency.'
Facts First
- HHS confirmed the FDA blocked publication of studies on COVID-19 and shingles vaccines.
- The CDC scrapped a separate study that found vaccines sharply cut emergency care and hospitalization risk for healthy adults.
- The acting CDC director rejected the study over methodological concerns.
- Two FDA studies were accepted for journals but agency officials directed scientists to withdraw them.
- One withdrawn FDA manuscript concluded the benefits of vaccination outweigh the risks.
What Happened
The Department of Health and Human Services (HHS) confirmed that the Food and Drug Administration (FDA) blocked the publication of studies regarding the safety and efficacy of vaccines against COVID-19 and shingles. Separately, last month, the Centers for Disease Control and Prevention (CDC) scrapped a scientifically vetted study that was previously scheduled for publication. The acting CDC director rejected that study, citing concerns about its methodology.
Why this Matters to You
These actions by federal health agencies may affect public trust in the information you receive about vaccine safety and effectiveness. The scrapped CDC study, which found vaccines sharply cut the risk of emergency care and hospitalization among healthy adults, could have informed your personal health decisions. The blocking of FDA studies, including one whose manuscript concludes the benefits of vaccination outweigh the risks, may lead to questions about the completeness of the data guiding public health recommendations.
What's Next
The pledge from Health Secretary Robert F. Kennedy for 'radical transparency' suggests there may be increased scrutiny of internal agency decisions regarding scientific publication. The public release of the full manuscripts for the blocked FDA studies could be a next step to address transparency concerns. The methodological debate that led to the CDC study's rejection may prompt further review or a revised analysis.